Ipsen

At the heart of what we do at Ipsen is a culture of innovation and a steadfast commitment to improving the lives of patients around the world. Founded in 1929 by Henri Beaufour, Ipsen has built a legacy of pioneering biopharmaceutical development, focusing on critical therapeutic areas such as Oncology, Rare Disease, and Neuroscience. As a mid-sized global biopharmaceutical company, we balance our size with agility, enabling us to respond rapidly to the evolving needs of healthcare. Our passionate team of over 5,000 dedicated professionals works every day to discover, innovate, and deliver transformative medicines that make a real difference.

Our strategic vision is encapsulated in our motto, "Focus. Together. For patients & society". We are committed to ensuring that our innovative treatments reach those who need them most, thereby enhancing their health outcomes and overall quality of life. We leverage our vast network of collaborations with other biopharmaceutical companies, academic institutions, and patient organizations to enrich our pipeline and drive meaningful advancements in the field. Sustainability is also a core component of our mission, ensuring that as we progress, we remain responsible stewards of our planet and actively contribute to a healthier future for all.